Inventor · disambiguated record
Tihamer Orban
Also filed as: ORBAN TIHAMER
6 granted patents·17 pending applications·16 citations·filing 2002–2025
78Inventor score
Top patents by PatentIndex Score
23 records- 0186US8735359B2Combinations of modalities for the treatment of diabetesORBAN TIHAMER·Filed 2012·Granted May 27, 2014·5 cites·5 claims
- 0278US8652488B2Insulin B chain autoantigen compositionORBAN TIHAMER·Filed 2006·Granted Feb 18, 2014·5 cites·12 claims
- 0377US11286303B2CTLA4 fusion proteins for the treatment of diabetesPHAIM PHARMA LTD·Filed 2019·Granted Mar 29, 2022·2 cites·20 claims
- 0476US2023333094A1Diabetes BiomarkersPHAIM PHARMA LTD·Filed 2023·Application pending·0 cites
- 0574US2025237643A1Diabetes BiomarkersPHAIM PHARMA LTD·Filed 2025·Application pending·0 cites
- 0673US2024058442A1Combinations of Modalities for the Treatment of DiabetesPHAIM PHARMA LTD·Filed 2023·Application pending·0 cites
- 0772US10233242B2CTLA4 fusion proteins for the treatment of diabetesDMNOMORE·Filed 2014·Granted Mar 19, 2019·3 cites·13 claims
- 0871US10716836B2Methods for treating autoimmune disease by inducing autoantigen-specific regulatory CD4+ T cellsORBAN TIHAMER·Filed 2008·Granted Jul 21, 2020·1 cites·10 claims
- 0966US2014220015A1Combinations of modalities for the treatment of diabetesORBAN BIOTECH LLC·Filed 2014·Application pending·0 cites
- 1062US2019137483A1Diabetes biomarkersDMNOMORE·Filed 2018·Application pending·0 cites
- 1161US2024316168A1Immunomodulatory Therapy For Type 1 Diabetes Mellitus AutoimmunityPHAIM PHARMA LTD·Filed 2024·Application pending·0 cites
- 1259US2020268883A1Combinations of modalities for the treatment of diabetesDMNOMORE·Filed 2020·Application pending·0 cites
- 1357US2024361217A1Psoriasis and Other Autoimmune Diseases Antigen Immune Modulator (AIM) Therapeutic PlatformPHAIM PHARMA LTD·Filed 2024·Application pending·0 cites
- 1456US2013316375A1Diabetes biomarkersORBAN BIOTECH LLC·Filed 2013·Application pending·0 cites
- 1554US2019151445A1Combinations of modalities for the treatment of diabetesDMNOMORE·Filed 2018·Application pending·0 cites
- 1651US2014099306A1Ctla4 fusion proteins for the treatment of diabetesORBAN BIOTECH LLC·Filed 2013·Application pending·0 cites
- 1749US2021353727A1Immunomodulatory therapy for type 1 diabetes mellitus autoimmunityPHAIM PHARMA LTD·Filed 2021·Application pending·0 cites
- 1849US2003045467A1Autoantigen compositionFiled 2002·Application pending·0 cites
- 1948US2016299128A1Diabetes biomarkersDMNOMORE·Filed 2016·Application pending·0 cites
- 2046US11040093B2Immunomodulatory therapy for type 1 diabetes mellitus autoimmunityORBAN TIHAMER·Filed 2015·Granted Jun 22, 2021·0 cites·11 claims
- 2145US2024277768A1Individualized Cell Therapy Using Patient-Derived Antigen-Specific Regulatory T CellsORBAN TIHAMER·Filed 2022·Application pending·0 cites
- 2245US2021404921A1Psoriasis and other autoimmune diseases antigen immune modulator (aim) therapeutic platformPHAIM PHARMA LTD·Filed 2021·Application pending·0 cites
- 2340US2024285732A1Patient Profiling for Antigen-Specific Immunomodulatory TherapiesPHAIM PHARMA LTD·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →